Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Liposomal Vincristine in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00006383. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Phase I/II Feasibility Study Combining Brentuximab Vedotin With Second Line Salvage Chemotherapy (DHAP) in Hodgkin Lymphoma Patients
ClinicalTrials.gov study NCT02280993. IPD Sharing: Not stated. Countries: 4. Publications: 3.
A Study of Escalating Doses of Polatuzumab Vedotin in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia and Polatuzumab Vedotin in Combination With
ClinicalTrials.gov study NCT01290549. IPD Sharing: Not stated. Countries: 4. Publications: 3.
CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL
ClinicalTrials.gov study NCT00586391. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Bortezomib (Velcade) in Combination With Dexamethasone to Treat Patients With Relapsed Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00148018. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Brain Integrity in Survivors of Hodgkin Lymphoma Treated With Thoracic Radiation
ClinicalTrials.gov study NCT01820117. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Lowdose Nivolumab in Combination With AVD as Front Line Therapy for Classic Hodgkin's Lymphoma
ClinicalTrials.gov study NCT05772624. IPD Sharing: NO. Countries: 1. Publications: 5.
Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma
ClinicalTrials.gov study NCT01868451. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Phase Ib Study of Rocbrutinib in Combination with R-CHOP in Patients with Newly Diagnosed B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT06251180. IPD Sharing: NO. Countries: 1. Publications: 2.
A Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With CD20-Positive B-Cell Non Hodgkin Lymphoma
ClinicalTrials.gov study NCT01569750. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00012051. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Chemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01290120. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma
ClinicalTrials.gov study NCT01896999. IPD Sharing: Not stated. Countries: 1. Publications: 3.
CCCG-HD-2018 for Children and Adolescents With Newly Diagnosed Hodgkin Lymphoma
ClinicalTrials.gov study NCT04726501. IPD Sharing: YES. Countries: 1. Publications: 4.
A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma
ClinicalTrials.gov study NCT01060904. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Rituximab in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
ClinicalTrials.gov study NCT00003849. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Safety, Tolerability, and Efficacy of AT101 in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT05338931. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Plerixafor Plus Granulocyte Colony-Stimulating Factor For Mobilization And Collection Of Peripheral Hematopoietic Stem Cells In Japanese Participants With Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02221492. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT02342782. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic Leukemia
ClinicalTrials.gov study NCT02153580. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.